Claris Lifesciences gets reaffirmation of credit ratings

From India Rating & Research

Claris Lifesciences announced that the 'India Rating & Research (Ind-Ra)' has affirmed Claris Lifesciences ("CLL") Long Term Rating at 'IND A' with a "Stable" outlook.

Powered by Capital Market - Live News